메뉴 건너뛰기




Volumn 22, Issue 2, 2012, Pages 145-147

A case of allergic bronchopulmonary aspergillosis treated with omalizumab

Author keywords

Aspergillus; Aspergilosis; Omalizumab

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; ITRACONAZOLE; OMALIZUMAB; PRECIPITIN; PREDNISONE;

EID: 84860230285     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (19)

References (7)
  • 1
    • 0031848952 scopus 로고    scopus 로고
    • Cell mediated immunology in allergic bronchopulmonary aspergillosis
    • Knusten AP, Chauhan B, Slavin RS. Cell mediated immunology in allergic bronchopulmonary aspergillosis. Immunol Allergy Clin N Am. 1998;18:575-600.
    • (1998) Immunol Allergy Clin N Am , vol.18 , pp. 575-600
    • Knusten, A.P.1    Chauhan, B.2    Slavin, R.S.3
  • 2
    • 0031307361 scopus 로고    scopus 로고
    • Aspergilosis broncopulmonar alérgica e itraconazol
    • Martinez A., Herrera. Aspergilosis broncopulmonar alérgica e itraconazol. Arch Bronconeumol. 1997;33(11):599-600.
    • (1997) Arch Bronconeumol , vol.33 , Issue.11 , pp. 599-600
    • Martinez, A.1    Herrera2
  • 3
    • 72049122135 scopus 로고    scopus 로고
    • Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis
    • Brinkmann F, Schwerk N, Hansen G, Ballmann M. Steroid dependency despite omalizumab treatment of ABPA in cystic fibrosis. Allergy. 2010;65(1):134-5.
    • (2010) Allergy , vol.65 , Issue.1 , pp. 134-135
    • Brinkmann, F.1    Schwerk, N.2    Hansen, G.3    Ballmann, M.4
  • 4
    • 66749112825 scopus 로고    scopus 로고
    • Omalizumab for treatment of ABPA exacerbations in CF patients
    • Lebecque P, Leonard A, Pilette C. Omalizumab for treatment of ABPA exacerbations in CF patients. Pediatr Pulmonol. 2009;44(5):516.
    • (2009) Pediatr Pulmonol , vol.44 , Issue.5 , pp. 516
    • Lebecque, P.1    Leonard, A.2    Pilette, C.3
  • 5
    • 56849094458 scopus 로고    scopus 로고
    • Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab)
    • Kanu A, Patel K. Treatment of allergic bronchopulmonary aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatr Pulmonol. 2008;43(12):1249-51.
    • (2008) Pediatr Pulmonol , vol.43 , Issue.12 , pp. 1249-1251
    • Kanu, A.1    Patel, K.2
  • 6
    • 44949162045 scopus 로고    scopus 로고
    • Steroid-sparing effect of omalizumab for allergic broncho-pulmonary aspergillosis and cystic fibrosis
    • Zirbes JM, Milla CE. Steroid-sparing effect of omalizumab for allergic broncho-pulmonary aspergillosis and cystic fibrosis. Pediatr Pulmonol. 2008;43(6):607-10.
    • (2008) Pediatr Pulmonol , vol.43 , Issue.6 , pp. 607-610
    • Zirbes, J.M.1    Milla, C.E.2
  • 7
    • 33947600594 scopus 로고    scopus 로고
    • Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody
    • Van der Ent CK, Hoekstra H, Rijkers GT. Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti- IgE antibody. Thorax. 2007;62(3):276-7.
    • (2007) Thorax , vol.62 , Issue.3 , pp. 276-277
    • van der Ent, C.K.1    Hoekstra, H.2    Rijkers, G.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.